文献速递神经肌肉病

反射算法提高重症肌无力自身抗体检测准确性

Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
PubMed 文献 · Neurology · 2020-09-16

回顾性分析4年内433份MG血清学检测样本,评估AChR-Bi、AChR-Mo、STR及反射检测MuSK等抗体的诊断价值。AChR-Bi>0.02 nmol/L灵敏度90%、特异度90%;对AChR-Bi阳性者反射检测AChR-Mo可将特异度提至95%并减少45%假阳性。STR及其他反射检测肿瘤相关抗体未提供超越标准胸部CT的额外价值。

要点

  • AChR-Bi>0.02 nmol/L诊断MG灵敏度90%、特异度90%。
  • AChR-Bi阳性时反射检测AChR-Mo,特异度达95%,假阳性减少45%。
  • STR及其他反射肿瘤相关抗体不优于标准胸部CT。

核心结论

  • 对AChR-Bi阳性病例反射检测AChR-Mo可提高MG血清学诊断准确性。
  • STR及其他反射肿瘤评估抗体在MG诊断时未提供超越标准胸部CT的价值。
  • AChR-Bi和AChR-Mo数值越高,诊断特异度越高。

研究设计与样本

  • 回顾性分析2012-2015年4年间433份MG血清学检测样本。
  • 所有患者均检测AChR-Bi、AChR-Mo和STR抗体,阴性者反射检测MuSK。
  • 以临床-电诊断标准及肿瘤评估作为确认或排除依据。

主要发现

  • 433份样本中133份(31%)符合MG的临床-电诊断标准。
  • AChR-Bi>0.02 nmol/L时灵敏度90%,14例阴性(6例眼肌型、7例全身型、1例MuSK型),特异度90%(31例假阳性)。
  • AChR-Mo>20%丢失时特异度92%(24例假阳性),灵敏度降至85%。
  • AChR-Bi阳性时反射检测AChR-Mo,特异度95%,假阳性从31例降至17例(减少45%),维持AChR-Bi 90%灵敏度。
  • 121例MG样本CT评估发现16例胸腺瘤;22例有既往或后续癌症;STR及反射抗体在合并肿瘤的MG中未更常见。

关键数值与推荐

  • AChR-Bi阳性定义为>0.02 nmol/L,用于MG初筛,灵敏度90%、特异度90%。
  • AChR-Mo阳性定义为>20%丢失,用于AChR-Bi阳性病例反射检测,特异度95%。
  • 对STR及反射抗体阳性者行全身CT(n=34),未发现额外癌症。

临床怎么用

  • 对疑似MG患者,可先检测AChR-Bi,阳性者反射检测AChR-Mo以提高特异度。
  • AChR-Bi和AChR-Mo数值较高时诊断特异度更高,可辅助判读。
  • 不推荐用STR及其他反射肿瘤相关抗体替代标准胸部CT进行胸腺瘤筛查。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To improve myasthenia gravis (MG) autoantibody testing. METHODS: MG serologic tests with confirmatory or refuting clinical-electrodiagnostic (EDX) testing and cancer evaluations were reviewed over 4 years (2012-2015). All patients had acetylcholine receptor-binding (AChR-Bi), modulating (AChR-Mo), and striational (STR) autoantibody testing, and negatives reflexed to muscle-specific kinase (MuSK). Thymoma and cancer occurrences were correlated with STR and reflexed glutamic acid decarboxylase 65 (GAD65), ganglionic acetylcholine receptor (α3), collapsin response mediating protein-5, and voltage-gated potassium channel complex autoantibodies. RESULTS: Of 433 samples tested, 133 (31%) met clinical-EDX criteria for MG. Best sensitivity (90%) occurred at AChR-Bi >0.02 nmol/L, leaving 14 negative (6 ocular MG, 7 generalized MG, 1 MuSK MG) with specificity 90% (31 false-positives). Using AChR-Mo antibodies (>20% loss), specificity was better (92%, 24 false-positives), but sensitivity dropped (85%). Specificity improved (95%) by testing AChR-Mo when AChR-Bi are positive, resulting in 45% reduction of false-positives (31-17), maintaining AChR-Bi 90% sensitivity. Cutoff values recommended by area under the curve analysis did not outperform this approach. AChR-Bi and AChR-Mo values were significantly higher in true-positives. CT evaluations in 121 MG samples revealed 16 thymomas. Historical or subsequent cancers occurred in 22. STR and reflexed autoantibodies were not more common in MG with thymoma or other cancers. Full-body CT (n = 34) was performed in those with STR and reflex autoantibody positivity, but without additional cancers found. CONCLUSION: Accuracy of MG serologic testing is improved by reflexing AChR-Bi-positive cases to AChR-Mo. STR and other reflexed cancer evaluation autoantibodies did not provide value beyond standard CT chest imaging at the time of MG diagnosis. Diagnostic certainty is informed by AChR-Bi and AChR-Mo with higher values increasing specificity.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Shelly S, Paul P, Bi H, et al. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm. Neurology. 2020. PMID: 32938782. doi:10.1212/WNL.0000000000010910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。